Extensive Sequence and Structural Evolution of Inhibitory Antibodies to Arginase2 Enabled by an Unbiased Approach to Affinity Maturation

8 views

|

December 5, 2022

  • Share
  • Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Stuart Haynes discussed an unbiased approach to affinity maturation via extensive sequence and structural evolution.

    Analytical TechniquesBiopharmaDrug DiscoveryNext-Generation Sequencing

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.